Identification of synthetic chemosensitivity genes paired with BRAF for BRAF/MAPK inhibitors.

Scientific Reports
Kye Hwa LeeKwangsoo Kim

Abstract

Molecular-targeted approaches are important for personalised cancer treatment, which requires knowledge regarding drug target specificity. Here, we used the synthetic lethality concept to identify candidate gene pairs with synergistic effects on drug responses. A synergistic chemo-sensitivity response was identified if a drug had a significantly lower half-maximal inhibitory concentration (IC50) in cell lines with a pair of mutated genes compared with those in other cell lines (wild-type or one mutated gene). Among significantly damaging mutations in the Genomics of Drug Sensitivity in Cancer database, we found 580 candidate synergistic chemo-sensitivity interaction sets for 456 genes and 54 commercial drugs. Clustering analyses according to drug/gene and drug/tissue interactions showed that BRAF/MAPK inhibitors clustered together; 11 partner genes for BRAF were identified. The combined effects of these partners on IC50 values were significant for both drug-specific and drug-combined comparisons. Survival analysis using The Cancer Genome Atlas data showed that patients who had mutated gene pairs in synergistic interaction sets had longer overall survival compared with that in patients with other mutation profiles. Overall, this...Continue Reading

References

May 18, 2001·Nature·F R Appelbaum
Nov 19, 2004·Nature·Charles Sawyers
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Neil E Bhola, Jennifer R Grandis
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Apr 16, 2010·Nature·UNKNOWN International Cancer Genome ConsortiumHuanming Yang
Feb 1, 2011·Journal of Molecular Cell Biology·Amal Aly, Shridar Ganesan
May 3, 2011·Nature Reviews. Drug Discovery·Denise A Chan, Amato J Giaccia
Sep 28, 2013·Nature Genetics·UNKNOWN Cancer Genome Atlas Research NetworkJoshua M Stuart
Nov 5, 2013·Nature·Cory M JohannessenLevi A Garraway
Nov 23, 2013·Cancer Discovery·Eliezer M Van AllenUNKNOWN Dermatologic Cooperative Oncology Group of Germany (DeCOG)
Jun 25, 2014·Nature Reviews. Cancer·Matthew HolderfieldMartin McMahon
Oct 31, 2014·Nucleic Acids Research·Simon A ForbesPeter J Campbell
Nov 27, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Douglas B JohnsonDirk Schadendorf
Dec 4, 2015·Nature Protocols·Robert VaserPauline C Ng
Dec 26, 2015·Nucleic Acids Research·Antonio ColapricoHoutan Noushmehr
Nov 16, 2016·Trends in Pharmacological Sciences·Xiaolan Deng, Yusuke Nakamura
Feb 12, 2017·Cell·David M HymanJosé Baselga
Jun 4, 2017·The Oncologist·Emilie M J van BrummelenJan H M Schellens
Jun 27, 2017·Nature Reviews. Genetics·Nigel J O'NeilPhilip Hieter
Dec 24, 2018·Database : the Journal of Biological Databases and Curation·Sarah E HuntFiona Cunningham
May 7, 2019·Frontiers in Oncology·Stephen A Luebker, Scott A Koepsell

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Software Mentioned

Bioconductor
TCGABiolinks
R
PolyPhen
TCGAanalyze
Ensembl
SIFT
Python
Ensembl Variant Effect Predictor
R package TCGAbiolinks

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.